BFH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bread Financial Holdings Inc (BFH) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown strong financial performance in the latest quarter and improving credit metrics, the recent price decline and lack of strong trading signals suggest waiting for a more favorable entry point. Additionally, mixed analyst ratings and a bearish options sentiment indicate caution.
The stock shows mixed technical indicators. The MACD is positive but contracting, RSI is neutral at 34.663, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its support level (S2: 70.717), and the recent price drop of -4.95% in the regular market and -1.91% post-market suggests bearish momentum.
Strong Q4 financial performance with revenue up 1.46% YoY, net income up 657.14% YoY, and EPS up 721.43% YoY.
Improved credit metrics, including reduced net principal losses and lower delinquency rates.
Analysts like UBS and Evercore ISI have upgraded the stock with higher price targets, citing improving fundamentals and valuation upside.
Recent price decline of -4.95% in the regular market and -1.91% post-market.
Mixed analyst ratings, with some firms maintaining 'Underweight' or 'Hold' ratings.
Bearish sentiment in the options market, as indicated by high put-call ratios.
Hedge funds and insiders show neutral trading trends, indicating no significant interest.
In Q4 2025, Bread Financial reported strong financial growth. Revenue increased by 1.46% YoY to $1.041 billion. Net income surged by 657.14% YoY to $53 million, and EPS rose by 721.43% YoY to $1.15. Gross margin improved to 80.88%, up 4.37% YoY. These results indicate robust profitability and operational efficiency.
Analyst sentiment is mixed. Positive upgrades include UBS initiating coverage with a 'Buy' rating and a $92 price target, and Evercore ISI upgrading to 'Outperform' with a $90 price target. However, Barclays and Morgan Stanley maintain 'Underweight' ratings with lower price targets, citing modest growth and cautious outlooks. The average price target range is $61-$92, reflecting uncertainty among analysts.
